Name: Eli Lilly and Company (LLY) Earnings Call
Start: 2026-10-29

Recent quarters

Latest 4 quarters

Beat in 4 of 4 · beat then fell 0 · average move ⁦±7.2%⁩

Quarter	EPSReported / estimate	RevenueReported / estimate	Reaction
Q2 FY2026 2026-08-05	8.38 / 6.40 +30.9%	$22.97B / $20.82B +10.3%	+4.86% ⁦+5.06⁩ pts vs SPY
Q1 FY2026 2026-04-30	8.55 / 6.97 +22.7%	$19.80B / $17.82B +11.1%	+9.80% ⁦+8.80⁩ pts vs SPY
Q4 FY2025 2026-02-04	7.54 / 6.91 +9.1%	$19.29B / $17.94B +7.5%	+10.33% ⁦+10.81⁩ pts vs SPY
Q3 FY2025 2025-10-30	7.02 / 5.69 +23.4%	$17.60B / $16.05B +9.6%	+3.81% ⁦+4.91⁩ pts vs SPY

Reported / estimate

Q2 FY2026 · 2026-08-05+4.86%
EPS8.38 / 6.40+30.9%
Revenue$22.97B / $20.82B+10.3%
Q1 FY2026 · 2026-04-30+9.80%
EPS8.55 / 6.97+22.7%
Revenue$19.80B / $17.82B+11.1%
Q4 FY2025 · 2026-02-04+10.33%
EPS7.54 / 6.91+9.1%
Revenue$19.29B / $17.94B+7.5%
Q3 FY2025 · 2025-10-30+3.81%
EPS7.02 / 5.69+23.4%
Revenue$17.60B / $16.05B+9.6%

Reaction is the close of the reacting session versus the previous close. The gap to SPY is in percentage points.

Next report

2026-10-29

In 2 daysQ3 FY2026BMO· Expected date

83 days ago

⁦+30.9%⁩EPS Beat

2026-08-05Q2 FY2026BMO

⁦+4.86%⁩

⁦+5.06⁩ pts vs SPY

Session ⁦2026-08-05⁩